Shawn focuses his practice on developing business-oriented patent strategies for biotechnology, pharmaceutical and medical device companies in the US and abroad. This work includes drafting and prosecuting patent applications, preparing freedom to operate opinions and counseling clients on Food and Drug Administration exclusivity strategies. Shawn also has represented many prominent life sciences investors in intellectual property due diligence matters for numerous financing transactions, including licensing, venture capital financings, initial public offerings and M&A transactions. He also has worked on multiple patent litigation matters before the US Patent and Trademark Office – including inter partes review and post-grant review proceedings – and provided litigation support in district court cases.
